Michelle Kenyon, King’s College Hospital NHS Foundation Trust, London, briefly discusses a talk on late effect surveillance following allogeneic stem cell transplant (alloSCT). Ms Kenyon highlights the publication of the new long-term effects screening guidelines, as well as emphasizing the need to give advice to patients and educate them on lifestyle behaviors that will allow them to recover and live to their full potential following transplantation. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.